Abstract
In 1992, The Danish Medical Research Council established a national committee on scientific dishonesty with the twofold task of handling cases of scientific misconduct and taking preventive initiatives. Scientific dishonesty was proven in only five cases, but in another nine cases lesser degrees of deviations from good scientific practice were found. The experiences from a total of 24 treated cases indicated that three key areas were at the basis of most of the accusations and the deviations from good practice: uncertainty about 1) authorship, about 2) rights and duties to use scientific data and about 3) agreements at the initiation of joint studies. As a consequence guidelines on good practice have been issued on these key subjects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersen, D., Attrup, L., Axelsen N. Riis P. (1992) Scientific dishonesty and good scientific practice. Danish Medical Research Council, Copenhagen.
Andersen D. (1998) Cases during DCSD’s first five years, in: Annual Report 1997, The Danish Committee on Scientific Dishonesty, Copenhagen: 9–14.
The Danish committee on Scientific Dishonesty (1996) Annual Report 1995, The Danish Committee on Scientific Dishonesty, Copenhagen: 78–80.
The Danish Committee on Scientific Dishonesty (1998) Annual Report 1997, The Danish Committee on Scientific Dishonesty, Copenhagen: 44.
The Danish Committee on Scientific Dishonesty (1995) Annual Report 1994, The Danish Committee on Scientific Dishonesty, Copenhagen: 57–58.
The Danish Committee on Scientific Dishonesty (1997) Annual Report 1996, The Danish Committee on Scientific Dishonesty, Copenhagen: 47–49.
The Danish Committee on Scientific Dishonesty (1994) Annual Report 1993, The Danish Committee on Scientific Dishonesty, Copenhagen: 48–49.
The Danish committee on Scientific dishonesty (1995) Annual Report 1994, The Danish Committee on Scientific Dishonesty, Copenhagen: 58–59.
The Danish committee on Scientific Dishonesty (1997) Guidelines for the presentation of experimental protocols and reports, data documentation and data storage in basic health research, Danish Medical Bulletin 44: 87–88.
The Danish Committee on Scientific Dishonesty (1997) Guidelines for the presentation of research plans and protocols, data documentation and data storage in clinical and clinical-epidemiological research, Danish Medical Bulletin 44: 88–89.
The Danish Committee on Scientific Dishonesty (1999) Guidelines on good scientific practice, Danish Medical Bulletin 46: 61–67.
Guidelines for the conduct of research within the public health service (1992) U.S. Department of health and human services.
EEC note for guidance (1990) Good clinical practice for trials on medicinal products in the European Community. CPMB working party on efficacy of medicinal products. Pharmacology and Toxicology 67: 361–372.
Good clinical research practice (1992) The Association of the British Pharmaceutical Industry. London.
Harvard Medical School (1992) Faculty policies on integrity in science, Boston, MA.
Evered, D., Lazar, P. (1996) Misconduct in medical research. European Medical Research, Newsletter, April, Strasbourg.
Macrina, F.L. (1995) Scientific integrity, American Society for Microbiology, Washington, DC.
International Committee of Medical Journal Editors. (1997) Uniform Requirements for Manuscripts Submitted for Biomedical Journals. Nordisk Medicin 112: 55–60.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andersen, D. From case management to prevention of scientific dishonesty in Denmark. SCI ENG ETHICS 6, 25–34 (2000). https://doi.org/10.1007/s11948-000-0019-x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11948-000-0019-x